October 16, 2019 | Deborah Kotz
Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)
Director of Media Relations
Office of Public Affairs & Communications
University of Maryland School of Medicine
Tuesday, February 09, 2021
UM School of Medicine Researchers Find that Misuse of Opioid Drugs During Pregnancy Could Have Lasting Impact on Child’s Development from Infancy Through Teen Years
As the number of pregnant women using opioid drugs continues to rise, questions have been raised about the long-term health effects on children exposed to these drugs in the womb. Researchers at the University of Maryland School of Medicine now have preliminary but striking evidence that suggests that such exposure can cause long-lasting impairment in the brain’s ability to process sensory information. These impairments may give rise to autism, attention deficit hyperactivity disorder, and substance use disorders during adolescence. The landmark study, recently published in Journal of Neuroscience, used a preclinical model to study the issue and found that newborn mice exposed to the opioid fentanyl in the womb developed withdrawal symptoms and sensory processing disorders that lasted at least until adolescence.
Thursday, April 16, 2020
Asaf Keller, PhD, Professor and Interim Chair of the Department of Anatomy & Neurobiology at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, have announced the formation of a new research center to study the long-term health effects on the brains of children born to women who use drugs and alcohol during pregnancy. The Center for Substance Use in Pregnancy will conduct pre-clinical and clinical neuroscience research, focusing on the use of marijuana, opioids, nicotine and alcohol, all of which have increased dramatically in recent years.
Thursday, February 27, 2020
Jill RachBeisel, MD, Interim Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), along with UMSOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Gloria Reeves, MD, Associate Professor of Psychiatry, has been appointed to serve as the Vice Chair for Research of the Department.
Thursday, January 16, 2020
University of Maryland School of Medicine Research Shows That Older Patients With Untreated Sleep Apnea Need Greater Medical Care
Obstructive sleep apnea (OSA) is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death. Researchers at the University of Maryland School of Medicine (UMSOM) found that the medical costs are substantially higher among older adults who go untreated for the disorder.
Thursday, April 04, 2019
Health and addiction treatment officials from the Caroline County Health Department, Maryland Department of Health, the Maryland Opioid Operational Command Center, and the University of Maryland School of Medicine (UMSOM) in Denton, MD., launched the Eastern Shore Mobile Care Collaborative (ESMCC), a mobile system designed to provide state-of-the-art treatment for opioid disorders for those in need on the Maryland Eastern shore.
Wednesday, March 27, 2019
UMSOM Researchers Discover a Critical Receptor Involved in the Response to Fast-Acting Antidepressants Like Ketamine
Effective treatment of clinical depression remains a major mental health issue, with roughly 30 percent of patients who do not respond to any of the available treatments. Researchers at the University of Maryland School of Medicine (UMSOM) have discovered a crucial receptor called mGlu2 that is critical to the mechanism of fast-acting antidepressants such as ketamine when used to treat depression.
Tuesday, October 16, 2018
Bankole Johnson, DSc, MD, the Dr. Irving J. Taylor Professor and Chair of the Department of Psychiatry at the University of Maryland School of Medicine (UMSOM), has been named to receive the American Society of Addiction Medicine’s (ASAM) R. Brinkley Smithers Distinguished Scientist Award.
Friday, April 20, 2018
Scientists at the University of Maryland School of Medicine have for the first time found direct causal links between a key brain chemical and avoidance-behavior related to pain and fear.
Friday, January 05, 2018
Fighting Opioid Addiction from Baltimore to Garrett County: University of Maryland School of Medicine Rises to the Challenge
The opioid epidemic has been deadly for Maryland. In 2016, more than 2000 people in the state died from overdoses; in 2017, deaths rose another 40 percent, and deaths from the powerful synthetic opioid fentanyl were up nearly 140 percent. Last year, Gov. Larry Hogan declared a state of emergency in response to the opioid epidemic, saying the state needs an “all-hands-on-deck approach.”
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.